The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Reduced Risk of Colorectal Cancer among Long-Term Users of Aspirin and Nonaspirin Nonsteroidal Antiinflammatory Drugs
Abstract
Use of nonsteroidal antiinflammatory drugs (NSAIDs) has been associated with a reduced risk of colorectal cancer, but limited information is available on the effect of individual nonaspirin NSAIDs. In addition, the dose-response relation of aspirin in reducing the risk of colorectal cancer has not been described. We carried out a population-based cohort study with secondary case-control analysis to determine the association between the risk of colorectal cancer and use of aspirin and individual NSAIDs, including the role of dose and duration. The General Practice Research Database in the U.K. was the source population. We traced 943,903 persons 40-79 years of age and free of cancer and colorectal adenoma between January 1994 and September 1997. A total of 2,002 incident cases of colorectal cancer were ascertained. The incidence rate of colorectal cancer per 10,000 person-years was 7.3. The risk of colorectal cancer was reduced in users of nonaspirin NSAIDs and became evident after 6 months of continuous treatment. The adjusted relative risk was 0.5 (95% confidence interval = 0.4-0.7). The reduction in risk disappeared completely 1 year after stopping NSAID treatment. The risk of developing colorectal cancer was reduced in long-term users of aspirin at doses of 300 mg daily (relative risk = 0.6; 95% confidence interval = 0.4-0.9). Daily doses of 75 and 150 mg aspirin were not associated with a reduced risk of colorectal cancer. Our data support the existence of an important protective effect of nonaspirin NSAID continuous intake against colorectal cancer and point to a similar reduction in risk for aspirin at doses of at least 300 mg daily. One-year treatment with NSAIDs would prevent one case of colorectal cancer in a population of 1,000 persons 70-79 years of age.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Much data indicates that use of these drugs reduces colon cancer risk by 40–50%”
From Inflammation and cancer (2002) · cites this paper as [58]
In the citing paper
“and may be preventative for lung, oesophagus and stomach cancer57,58.”
From Inflammation and cancer (2002) · cites this paper as [58]
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
Eberhart, C. E., Coffey, R. J., Aramandla, R., Giardiello, F. M., Ferrenbach, S., & DuBois, R. N. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90246-1 · Cited by 2,512
Aspirin and the Risk of Colorectal Cancer in Women
Giovannucci, E. L., Egan, K. M., Hunter, D. J., Stampfer, M. J., Colditz, G. A., Willett, W. C., & Speizer, F. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509073331001 · Cited by 1,095
Aspirin use and risk of fatal cancer.
Thun, M. J., Namboodiri, M. M., Calle, E. E., Flanders, W. D., & Heath, C. W. (1993) · PubMed · Cited by 870
Jick, H., Jick, S. S., & Derby, L. E. (1991) · BMJ · doi:10.1136/bmj.302.6779.766 · Cited by 839
Aspirin Use and the Risk for Colorectal Cancer and Adenoma in Male Health Professionals
Giovannucci, E. L., Rimm, E. B., Stampfer, M. J., Colditz, G. A., Ascherio, A., & Willett, W. C. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-4-199408150-00001 · Cited by 784
Aspirin Use and Lung, Colon, and Breast Cancer Incidence in a Prospective Study
Schreinemachers, D. M., & Everson, R. B. (1994) · Epidemiology · doi:10.1097/00001648-199403000-00003 · Cited by 738
Kune, G. A., Kune, S., & Watson, L. F. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym193 · Cited by 654
Incidence of Cancer Among Patients With Rheumatoid Arthritis
Gridley, G., McLaughlin, J. K., Ekbom, A., Klareskog, L., Adami, H., Hacker, D. G., Hoover, R. N., & Fraumeni, J. F. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.4.307 · Cited by 580
Prophylactic aspirin and risk of peptic ulcer bleeding
Weil, J., Colin-Jones, D. G., Langman, M. J. S., Lawson, D. H., Logan, R., Murphy, M. S., Rawlins, M. D., Vessey, M. P., & Wainwright, P. (1995) · BMJ · doi:10.1136/bmj.310.6983.827 · Cited by 563
Research works printed but not linked: 4
- Vainio, 1997, Cancer Epidemiol Biomarkers Prev, 6, 749
- Kune, 1988, Cancer Res, 48, 4399
- Reeves, 1996, Cancer Epidemiol Biomarkers Prev, 5, 955
- Thun, 1993, Cancer Res, 53, 1322
Cited by
Sorted by citations
Items 201–300 of 358
PEG-Fmoc-Ibuprofen Conjugate as a Dual Functional Nanomicellar Carrier for Paclitaxel
Zhao, M., Huang, Y., Chen, Y., Xu, J., Li, S., & Guo, X. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00415 · Cited by 20
Oligo(3-hydroxybutanoate) conjugates with acetylsalicylic acid and their antitumour activity
Juzwa, M., Rusin, A., Zawidlak-Węgrzyńska, B., Krawczyk, Z., Obara, I., & Jedliński, Z. (2007) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2007.11.004 · Cited by 20
Hattori, K., Iida, K., Joraku, A., Tsukamoto, S., Akaza, H., & Oyasu, R. (2006) · British Journal of Urology · doi:10.1111/j.1464-410x.2006.06053.x · Cited by 20
Colon cancer prevention with NO-releasing NSAIDs
Kaza, C. S., Kashfi, K., & Rigas, B. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00003-5 · Cited by 20
Digoxin use and the risk for colorectal cancer
Boursi, B., Haynes, K., Mamtani, R., & Yang, Y. (2014) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3717 · Cited by 19
The Pharmacogenetic Impact of Inflammatory Genes on Bladder Cancer Recurrence
Gu, J. H., Grossman, H. B., Dinney, C. P., & Wu, X. (2005) · Pharmacogenomics · doi:10.2217/14622416.6.6.575 · Cited by 19
Daugherty, S. E., Platz, E. A., Shugart, Y. Y., Fallin, M. D., Isaacs, W. B., Chatterjee, N., Welch, R., Huang, W., & Hayes, R. B. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0117 · Cited by 19
Rating the environmental and genetic risk factors for colorectal cancer.
Toma, M., Beluşică, L., Stavarachi, M., Apostol, P., Spandole-Dinu, S., Radu, I., & Cimponeriu, D. (2012) · PubMed Central · Cited by 18
Dietary Intervention for Preventing Colorectal Cancer: A Practical Guide for Physicians
Kim, S. H., Moon, J. Y., & Lim, Y. J. (2022) · Journal of Cancer Prevention · doi:10.15430/jcp.2022.27.3.139 · Cited by 19
Guo, X., Xie, Y., Lian, S., Li, Z., Gao, Y., Zhou, X., Hu, P., Chen, M., Sun, Z., Tian, X., et al. (2017) · Biomedical Chromatography · doi:10.1002/bmc.4124 · Cited by 18
Nonsteroidal Anti-inflammatory Drug Use and Risk of Adenomatous and Hyperplastic Polyps
Murff, H. J., Shrubsole, M. J., Chen, Z., Smalley, W. E., Chen, H., Shyr, Y., Ness, R. M., & Zheng, W. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0107 · Cited by 18
Kumar, R. (2016) · Journal of Nanomedicine & Nanotechnology · doi:10.4172/2157-7439.1000e140 · Cited by 17
Spinster homolog 2 in cancers, its functions and mechanisms
Fang, L., Hou, J., Cao, Y., Shan, J., & Zhao, J. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109821 · Cited by 17
Pathogenic Role of Cyclooxygenase-2 in Cancer
Divvela, A. K. C., Challa, S. R., & Tagaram, I. (2010) · Eisei kagaku · doi:10.1248/jhs.56.502 · Cited by 17
Balza, E., Castellani, P., Delfino, L., Truini, M., & Rubartelli, A. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs360 · Cited by 16
Jacalin Has Chemopreventive Effects on Colon Cancer Development
Geraldino, T. H., Modiano, P., Veronez, L. C., Flória‐Santos, M., Garcia, S. B., & Pereira-da-Silva, G. (2017) · BioMed Research International · doi:10.1155/2017/4614357 · Cited by 16
Yu, H., Huang, J.-A., Yang, Y., Luo, H., Yu, J., Meier, J. J., Schrader, H., Bastian, A., Schmidt, W. E., & Schmitz, F. (2003) · Regulatory Peptides · doi:10.1016/s0167-0115(03)00084-3 · Cited by 16
Peleg, I. I., & Wilcox, C. M. (2002) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200202000-00003 · Cited by 16
The Role of Arachidonic Acid Regulatory Enzymes in Colorectal Disease
Abir, F., Alva, S., Kaminski, D. L., & Longo, W. E. (2005) · Diseases of the Colon & Rectum · doi:10.1007/s10350-005-0015-y · Cited by 16
Procalcitonin as a biomarker for infection-related mortality in cancer patients
Sedef, A. M., Köse, F., Mertsoylu, H., & Özyılkan, Ö. (2015) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0000000000000142 · Cited by 15
Diabetes but not insulin is associated with higher colon cancer mortality
Tseng, C. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i31.4182 · Cited by 15
Cancer and the Cyclo-oxygenase Enzyme
Hawk, E. T., Viner, J. L., Umar, A., Anderson, W. F., Sigman, C. C., & Guyton, K. Z. (2003) · American Journal of Cancer · doi:10.2165/00024669-200302010-00003 · Cited by 15
Molecular characterisation of canine nonsteroidal anti-inflammatory drug-activated gene (NAG-1)
Yamaguchi, K., Whitlock, N. C., Liggett, J. L., Legendre, A. Μ., Fry, M. M., & Baek, S. J. (2007) · The Veterinary Journal · doi:10.1016/j.tvjl.2006.12.001 · Cited by 15
Srinivasan, R., Yang, Y., Rubin, S. C., Morgan, M. A., & Lewis, J. D. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.00316.x · Cited by 15
Inflammation Targeted Gd3+-Based MRI Contrast Agents Imaging Tumor and Rheumatoid Arthritis Models
Leung, A. H.-H., Jin, J., Wang, S., Lei, H. C., & Wong, W. (2014) · Bioconjugate Chemistry · doi:10.1021/bc5001356 · Cited by 15
Prevalence of colorectal adenomatous polyps in patients with chronic obstructive pulmonary disease
Chun, E. M., Kim, S. W., & Lim, S. Y. (2015) · International Journal of COPD · doi:10.2147/copd.s83341 · Cited by 14
Jiang, Y., Su, Z., Li, C., Wang, R., Wen, Y., Liang, H., He, J., & Liang, W. (2020) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-020-03394-5 · Cited by 14
Polyamine metabolism and cancer prevention
Saunders, F. R., & WALLACE, H. M. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350364 · Cited by 14
Su Juan, F. E. I., Shu Dong, X. I. A. O., Peng, Y. S., Chen, X. Y., & Yao, S. H. I. (2006) · Chinese Journal of Digestive Diseases · doi:10.1111/j.1443-9573.2006.00258.x · Cited by 14
Zhang, H., Li, Y., Liu, Y., Liu, Y., & Chen, X. (2024) · Scientific Reports · doi:10.1038/s41598-024-61632-z · Cited by 14
Association Between Low-Dose Aspirin Use and Colorectal Cancer Incidence in Taiwan
Lin, H.-M. D., Vora, P., Soriano‐Gabarró, M., & Chan, K. A. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.26494 · Cited by 13
Yu, J. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i31.4911 · Cited by 13
Low-Dose Aspirin and Vitamin E
Jacobs, E. J., & Thun, M. J. (2005) · JAMA · doi:10.1001/jama.294.1.105 · Cited by 13
Effect of Suppressive Oligodeoxynucleotides on the Development of Inflammation-Induced Papillomas
Ikeuchi, H., Kinjo, T., & Klinman, D. M. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0290 · Cited by 12
Suppressive oligodeoxynucleotides reduce lung cancer susceptibility in mice with silicosis
Bode, C., Kinjo, T., Alvord, W. G., & Klinman, D. M. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu005 · Cited by 12
Çelik, B., Yalçın, A. D., Genç, G. E., Bulut, T., Genç, S., & Gümüşlü, S. (2016) · Biomedical Reports · doi:10.3892/br.2016.709 · Cited by 12
Clinical Implication of Serosal Change in Pathologic Subserosa‐Limited Gastric Cancer
Kim, J. M., Jung, H. S., Lee, J. S., Lee, H. H., Song, K. Y., Park, C. H., & Jeon, M. H. (2011) · World Journal of Surgery · doi:10.1007/s00268-011-1334-x · Cited by 12
Aspirin as a Chemoprevention Agent for Colorectal Cancer
Lee, C. S., McNamara, D. A., & O'Morain, C. A. (2012) · Current Drug Metabolism · doi:10.2174/138920012803341384 · Cited by 12
The discovery, development and novel actions of nimesulide
Rainsford, K. D. (2005) · Birkhäuser Basel eBooks · doi:10.1007/3-7643-7410-1_1 · Cited by 12
Zhang, H., Li, Y., Liu, G., & Chen, X. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05508-1 · Cited by 11
OxLDL as an Inducer of a Metabolic Shift in Cancer Cells
Bitorina, A. V., Oligschlaeger, Y., Ding, L., Yadati, T., Westheim, A. J. F., Houben, T., Vaes, R. D. W., Damink, S. W. M. O., Theys, J., & Shiri‐Sverdlov, R. (2021) · Journal of Cancer · doi:10.7150/jca.56307 · Cited by 12
Damnjanović, I., Najman, S. J., Stojanović, S., Stojanovic, D., Veljković, A., Kocić, H., Langerholc, T., Damnjanović, Z., & Pesic, S. (2015) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2015_044 · Cited by 11
Colorectal cancer incidence on the General Practice Research Database
Charlton, R. A., Snowball, J. M., Bloomfield, K., & de Vries, C. S. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3236 · Cited by 10
Do Older Adults Using NSAIDs Have a Reduced Risk of Colorectal Cancer?
Hoffmeister, M., Chang-Claude, J. C., & Brenner, H. (2006) · Drugs & Aging · doi:10.2165/00002512-200623060-00006 · Cited by 10
New Prognostic Scoring System for Incurable Stage IV Colorectal Cancer
Kishiki, T., Masaki, T., Mastuoka, H., Abe, N., Mori, T., & Sugiyama, M. (2016) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2016.17.2.597 · Cited by 10
Risk of Colorectal Cancer in Women With a Prior Diagnosis of Gynecologic Malignancy
Srinivasan, R., Yang, Y., Rubin, S. C., Morgan, M. A., & Lewis, J. D. (2007) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000225587.85953.06 · Cited by 10
Bošković, J., Dobričić, V., Keta, O. D., Korićanac, L., Žakula, J. J., Dinić, J., Stojanov, S. J., Pavić, A., & Cudina, O. A. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16060826 · Cited by 9
Zhou, X., Matskova, L., Zheng, S., Wang, X., Wang, Y., Xiao, X., Mo, Y., Wölke, M., Li, L., Zheng, Q., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.861916 · Cited by 9
Innovative Treatments to Counteract Endothelial Dysfunction in Chronic Kidney Disease Patients
Marrone, G., Cornali, K., Lauro, M. D., Ceravolo, M. J., Marco, L. D., di Villahermosa, S. M., Mitterhofer, A. P., & Noce, A. (2024) · Biomedicines · doi:10.3390/biomedicines12051085 · Cited by 12
Cycloxygenase-2 is Essential for the Survival and Proliferation of Gastric Cancer Cells
Ma, D., Liu, M., Wang, A., & Yang, H. (2011) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-011-9249-6 · Cited by 9
Viguier, J., Karsenti, D., Dorval, E. D., Bourlier, P., & de Calan, L. (2003) · EMC - Gastro-entérologie · doi:10.1016/s1155-1968(03)00067-1 · Cited by 9
Use of acetaminophen in relation to the occurrence of cancer: a review of epidemiologic studies
Weiss, N. S. (2016) · Cancer Causes & Control · doi:10.1007/s10552-016-0818-2 · Cited by 9
Colorectal Cancer Among Gout Patients Undergoing Colonoscopy
Slobodnick, A., Krasnokutsky, S., Lehmann, R. A., Keenan, R. T., Quach, J., François, F., & Pillinger, M. H. (2018) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0000000000000893 · Cited by 8
Lynch syndrome in colorectal cancer patients
Giraldez, M. D., Castellvı́-Bel, S., Balaguer, F., Gonzalo, V., Ocaña, T., & Castells, A. (2008) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.8.4.573 · Cited by 8
Charlton, R. A., Snowball, J. M., Bloomfield, K., & de Vries, C. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083203 · Cited by 8
Cyclo‐oxygenase‐2 over‐expression in sporadic colorectal carcinoma without lymph node involvement
Buecher, B., Heymann, M., Lièvre, A., Nguyen, J., Wilson, K., Bezieau, S., Mosnier, J., Galmiche, J. ‐., & Blottière, H. M. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01758.x · Cited by 8
Rheumatology and musculoskeletal medicine.
Davenport, G. (2004) · PubMed Central · Cited by 8
Yu, J., Wu, Y., Qin, Q., Lu, K.-Z., Yan, S., Liu, X., & Zheng, S. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i31.4908 · Cited by 7
Xinhua, X. U., Hu, G., Li, S., Xue, F., Li, D., Dai, D., & Chen, Y. (2006) · The Chinese-German Journal of Clinical Oncology · doi:10.1007/s10330-005-0400-y · Cited by 7
Colorectal Cancer among Users of Aspirin and Non-Steroidal Antiinflammatory Drugs
Chambers, S., Evans, L. E., & Krishnan, A. (2001) · Epidemiology · doi:10.1097/00001648-200107000-00020 · Cited by 7
Yahyaie, M., Morovati-Sharifabad, M., Salehi, E., Sarkargar, F., & Pourghanbari, G. (2021) · Jentashapir Journal of Cellular and Molecular Biology · doi:10.5812/jjcmb.112309 · Cited by 6
Androgen deprivation therapy and the risk of colorectal cancer in patients with prostate cancer
Assayag, J., Yin, H., Benayoun, S., Pollak, M., Suissa, S., & Azoulay, L. (2013) · Cancer Causes & Control · doi:10.1007/s10552-012-0132-6 · Cited by 6
β7 integrins contribute to intestinal tumor growth in mice
Das, S., Doñas, C., Akéus, P., Quiding‐Järbrink, M., Mora, J. R., & Villablanca, E. J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204181 · Cited by 6
Curcumin: A Challenge in Cancer Treatment
Basnet, P., & Škalko‐Basnet, N. (2012) · Journal of Nepal Pharmaceutical Association · doi:10.3126/jnpa.v26i1.6631 · Cited by 6
Ware, W. R. (2010) · Cited by 6
Epidemiology of Nonsteroidal Anti-Inflammatory Drugs and Colorectal Cancer
Thun, M. J., & Henley, S. J. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-302-6_3 · Cited by 6
Effects of Red Blood Cell Transfusions on Distant Metastases of Oral Squamous Cell Carcinomas
Brandenburg, L. S., Metzger, M. C., Poxleitner, P. J., Voss, P. J., Vach, K., Hell, J., Hasel, K., Weingart, J. V., Schwarz, S. J., & Ermer, M. A. (2021) · Cancers · doi:10.3390/cancers14010138 · Cited by 5
Clinical implications of cyclooxygenase-2 inhibitors
Kawahito, Y. (2007) · Inflammation and Regeneration · doi:10.2492/inflammregen.27.552 · Cited by 5
Schuemie, M. J., Weinstein, R. B., Ryan, P. B., & Berlin, J. A. (2021) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2021.104866 · Cited by 5
Colorectal Cancer: Epidemiology, Etiology, and Molecular Basis
Baxter, N. N., & Guillem, J. G. (2007) · Springer eBooks · doi:10.1007/978-0-387-36374-5_23 · Cited by 5
Awtry, E. H., & Loscalzo, J. (2007) · Elsevier eBooks · doi:10.1016/b978-012369367-9/50822-3 · Cited by 5
Prevención del cáncer colorrectal
Cardellach, F., & Castells, A. (2001) · Medicina Clínica · doi:10.1016/s0025-7753(01)72015-5 · Cited by 5
Aspirin and colorectal cancer?
Morgan, G. (2004) · European Journal of Public Health · doi:10.1093/eurpub/14.1.105 · Cited by 5
Non-steroidal anti-inflammatory drugs (NSAIDs) for colorectal cancer prevention
Hawk, E. T., Viner, J. L., Richmond, E. S., & Umar, A. (2003) · Cancer chemotherapy and biological response modifiers · doi:10.1016/s0921-4410(03)21036-x · Cited by 5
Ibuprofen in the Prevention and Therapy of Cancer
Harris, R. E. (2015) · doi:10.1002/9781118743614.ch13 · Cited by 5
Oleocanthal, a Natural anti-Inflammatory Compound in Extra Virgin Olive Oil
Cicerale, S., & Keast, R. (2010) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/187152310791110607 · Cited by 4
Kato, I., Lane, D. S., Womack, C. R., Bock, C. H., Hou, L., Lin, J., Wu, C., Dimmer, J. B., & Simon, M. S. (2017) · Journal of the American College of Nutrition · doi:10.1080/07315724.2017.1321505 · Cited by 4
Ota, Y., Imai, T., Hasumura, M., Cho, Y., Takami, S., OYAMADA, T., Hirose, M., Nishikawa, A., & Ogawa, K. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs097 · Cited by 4
Inflammation and matrix metalloproteinases: implications for cancer development
de Visser, K. E., & Coussens, L. M. (2004) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7861-6_4 · Cited by 4
Colorectal Cancer: Epidemiology, Etiology, and Molecular Basis
Moore, H. G., Baxter, N. N., & Guillem, J. G. (2011) · Springer eBooks · doi:10.1007/978-1-4419-1584-9_38 · Cited by 3
Ginderachter, J. A. V., Liu, Y., Devoogdt, N., Noël, W., Brys, L., Gh., G. H., Raes, G., Geldhof, A. B., Beschin, A., Revets, H., et al. (2008) · Springer eBooks · doi:10.1007/978-1-4020-6729-7_9 · Cited by 3
Müller, H., Plášilová, M., Russell, A., & Heinimann, K. (2003) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-55647-0_21 · Cited by 3
Cheng, Y. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i16.2420 · Cited by 3
Low-Dose Aspirin Affects the Clinicopathological Features of Gastric Cancer
Hwang, H. J., Youn, Y. H., Kim, J., Chung, J. B., & Lee, Y. C. (2006) · Digestion · doi:10.1159/000092248 · Cited by 3
Aspirina en la prevención del cáncer colorrectal
Zubiaurre, L., & Bujanda, L. (2011) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2011.01.004 · Cited by 3
Cyclo-Oxygenase-2 Inhibitors in Colorectal Cancer Prevention
Moshkowitz, M., & Arber, N. (2006) · American Journal of Cancer · doi:10.2165/00024669-200605060-00002 · Cited by 3
Clinical Effects of NSAIDs and COXIBs in Colon Cancer Prevention
Piazuelo, E., & Lanas, Á. (2016) · Springer eBooks · doi:10.1007/978-3-319-33889-7_13 · Cited by 3
A New Twist to Ibuprofen: Alternative Action in Alternative Splicing
Jordan, P., Gonçalves, V., & Matos, P. (2019) · European Medical Journal · doi:10.33590/emj/10311656 · Cited by 3
Mortality from colorectal cancer in Andalusia: findings in favor of mass screening
Ruiz-Ramos, M., Pujolar, A. E., & Bono, T. H. (2005) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082005000200005 · Cited by 3
Huang, Y., Lin, J., Chen, W., Shia, B., & Wu, S. (2025) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaf304 · Cited by 2
Cyclooxygenase-2 and Chronic Inflammation: Drivers of Colorectal Tumorigenesis
Bertagnolli, M. M. (2012) · Springer eBooks · doi:10.1007/978-1-4614-2367-6_10 · Cited by 2
Concept of chemoprevention in colorectal cancer
O'Morain, C. A. (2009) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v1.i1.21 · Cited by 2
Matrix Metalloproteinases: Mediators of Tumour-Host Cell Interactions
Diaz, R. J., Eichten, A., de Visser, K. E., & Coussens, L. M. (2005) · Springer eBooks · doi:10.1007/1-4020-3414-8_6 · Cited by 2
Pankova, O. V., Михайлович, П. В., Тузиков, С. А., & Denisov, Y. V. (2014) · Bulletin of Siberian Medicine · doi:10.20538/1682-0363-2014-3-100-110 · Cited by 2
MİDE KANSERİ HASTALARINDA PERİFERİK KAN SAYIMI İLE PROGNOZ ARASINDAKİ İLİŞKİ
Okuyucu, M., & Yücel, İ. (2019) · Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi · doi:10.26650/iuitfd.2018.0014 · Cited by 2
Clinical Applications of Aspirin
Schrör, K. (2008) · Wiley eBooks · doi:10.1002/9783527625994.ch4 · Cited by 2
Targeting the Arachidonic Acid Cascade in Cancer: Recent Advances in Enzyme Inhibitor Design
Vujić, Z. B., Savić, J. S., Cudina, O. A., Brborić, J. S., & Dobričić, V. (2026) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/0118715206424807251207200409 · Cited by 1
Ayub, M., & Islam, A. (2015) · OALib · doi:10.4236/oalib.1101830 · Cited by 1
The role of COX-2 in chemoprevention of colorectal cancer: A friend or an enemy?
Ferrández, Á., & Lanas, Á. (2006) · Current Colorectal Cancer Reports · doi:10.1007/s11888-006-0011-1 · Cited by 1
Goel, H., Thareja, S., Malla, P., Kumar, M., & Sinha, V. R. (2012) · International Journal of Toxicology · doi:10.1177/1091581812444140 · Cited by 1
Metadata
- Authors
- García Rodríguez, L. A., & Huerta-Alvarez, C.
- Venue
- Epidemiology
- Published
- 2001-01
- Volume
- 12
- Issue
- 1
- Pages
- 88-93
- ISSN
- 1044-3983 (ISSN-L)
- OpenAlex
- W1971370481
- Cited by
- 359
- References
- 29
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 5 · 2023: 8 · 2022: 4 · 2021: 5 · 2020: 11 · 2019: 6 · 2018: 11 · 2017: 10 · 2016: 16 · 2015: 15 · 2014: 11 · 2013: 14 · 2012: 19
- FWCI
- 16.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Keywords
- colorectal cancer, aspirin, nonsteroidal anti-inflammatory drugs, chemoprevention, dose-response relationship, long-term drug use, cancer incidence, colorectal adenoma
- MeSH terms
- Adenoma, Adult, Aged, Anti-Inflammatory Agents, Non-Steroidal, Aspirin, Female, United Kingdom, Humans, Male, Middle Aged, Risk Factors, Colorectal Neoplasms, Cohort Studies, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review